- Home
- CVAC vs OPK Comparison
CVAC vs OPK Comparison
Compare CVAC & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CVAC | OPK |
|---|---|---|
| Founded | 2000 | 2007 |
| Country | Germany | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.0B |
| IPO Year | 2020 | 1995 |
Fundamental Metrics
Financial Performance| Metric | CVAC | OPK |
|---|---|---|
| Price | $4.66 | $1.36 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 3 | 5 |
| Target Price | ★ $6.83 | $2.28 |
| AVG Volume (30 Days) | 1.3M | ★ 4.1M |
| Earning Date | 11-24-2025 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 94.02 | N/A |
| EPS | ★ 0.94 | N/A |
| Revenue | $83,000,117.00 | ★ $642,067,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $23.71 | N/A |
| P/E Ratio | $4.98 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.48 | $1.11 |
| 52 Week High | $5.72 | $2.04 |
Technical Indicators
Market Signals| Indicator | CVAC | OPK |
|---|---|---|
| Relative Strength Index (RSI) | 47.92 | 57.15 |
| Support Level | $4.26 | $1.24 |
| Resistance Level | $4.68 | $1.33 |
| Average True Range (ATR) | 0.17 | 0.05 |
| MACD | 0.04 | 0.01 |
| Stochastic Oscillator | 62.56 | 92.31 |
Price Performance
Historical ComparisonAbout CVAC CureVac N.V.
CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and COVID-19 vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.
About OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.